new tirzepatide drug F.D.A. Approves Obesity That Will Compete With Wegovy What to know about the

According to the FDA labeling, there are no clinically meaningful differences in absorption between these approved injection sites when proper technique is used

30 days average time to launch (vs

The right needle helps the dose reach the right layer of tissue, keeps the injection comfortable, and lowers the small risks that come with any injection

MM: Data curation, Investigation, Methodology, Software, Validation, Writing review & editing, Formal analysis, Visualization

The FAERS database is subject to reporting bias, lacks denominator data (total number of patients exposed), and cannot distinguish between coincidental associations and true drug-related effects